IMT Header
2013 Archived Content

Eighth Annual

Novel Vaccines: Innovation & Adjuvants

August 13-15

Keynote Speakers:

Peter PalesePeter Palese, Ph.D., Horace W. Goldsmith Professor and Chair, Microbiology, Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai


Michael OsterholmMichael T. Osterholm, Ph.D., MPH, Director, Center for Infectious Disease Research and Policy (CIDRAP), and Professor, Environmental Health Sciences, School of Public Health, University of Minnesota


Featured Speakers:

John TsangJohn Tsang, Ph.D., Chief, Systems Genomics and Bioinformatics Unit, LSB, and Head, Computational Systems Biology, Trans-NIH Center for Human Immunology (CHI), NAIAD-NIH


Manon CoxManon Cox, Ph.D., CEO, Protein Sciences


Nathalie GarçonNathalie Garçon, Ph.D., Vice President and Head, Global Center for Adjuvants and Technology Innovation, GlaxoSmithKline Biologicals


Derek O'HaganDerek O'Hagan, Ph.D., Global Head, Vaccine Delivery Research, Novartis Vaccines


Co-Located Event:


Emerging Cancer
Immunotherapies and Vaccines

August 13-14


Antibodies for Cancer

August 14-15

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

2015 IMVACS-The Immunotherapies & Vaccine Summit

Download Brochure 

2015 Final Agenda

View All Sponsors 

View Media Partners 

Exhibit Contract 

ImVacS Attendee Profile Icon 

See Who Attended ImVacS 2014! 

ImVacS Attendee Profile Statistics Attendee Profile: Over 300 international delegates from biotech, pharma, and more attend ImVacS every year. Don't miss networking and collaboration opportunities with vaccine and immunotherapy thought-leaders! View full details here.